BNP Paribas Financial Markets
ENFN

BNP Paribas Financial Markets’s Enfusion, Inc. ENFN Stock Holding History

BNP Paribas Financial Markets’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,208
Closed -$35.8K – 5728
2025
Q1 		$35.8K Sell
3,208
-49,299
-94% -$545K ﹤0.01% 4388
2024
Q4 		$541K Buy
+52,507
New +$507K ﹤0.01% 3247
2022
Q4 		– Sell
-9,413
Closed -$116K – 4716
2022
Q3 		$116K Buy
+9,413
New +$115K ﹤0.01% 3704

Other funds holding ENFN

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BNP Paribas Financial Markets's ENFN Position: Q2 2025 in Review

BNP Paribas Financial Markets sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 3,208 shares — an estimated $35.8K sold.

BNP Paribas Financial Markets first reported a position in ENFN in Q3 2022 and held it in 3 quarters. The position peaked at $541K in Q4 2024. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • BNP Paribas Financial Markets reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 3,208 Enfusion, Inc. shares in Q2 2025, an estimated $35.8K.
  • BNP Paribas Financial Markets first reported a position in Enfusion, Inc. in Q3 2022 and held it in 3 quarters.
  • BNP Paribas Financial Markets's Enfusion, Inc. position peaked at $541K in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2025, filed 14 Aug 2025.